BAYTRIL 25 FLAVOUR ANTIBACTERIAL ORAL SUSPENSION

Country: Awstralja

Lingwa: Ingliż

Sors: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredjent attiv:

ENROFLOXACIN

Disponibbli minn:

ELANCO AUSTRALASIA PTY LTD

INN (Isem Internazzjonali):

enrofloxacin(25mg/mL)

Għamla farmaċewtika:

ORAL SOLUTION/SUSPENSION

Kompożizzjoni:

ENROFLOXACIN ANTIBIOTIC Active 25.0 mg/ml

Unitajiet fil-pakkett:

15mL; 30mL; 8.5mL

Klassi:

VM - Veterinary Medicine

Manifatturat minn:

BAYER AUSTRALIA

Grupp terapewtiku:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Żona terapewtika:

ANTIBIOTIC & RELATED

Indikazzjonijiet terapewtiċi:

BACTERIAL INFECTION | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | INFECTIOUS SINUSITIS | STAPHYLOCOCCUS INTERMEDIUS | WOUND INFECTIONS | ABSCESSES | ACUTE RESPIRATORY INFECTIONS | AMOXYCILLIN SENSITIVE BACTERIA | ASSOCIATED WITH VIRAL DISEASE | BRONCHISEPTICA | BRONCHITIS | DEEP PYODERMAS | DISCHARGING SINUSES | ESCHERICHIA COLI | GRAM NEGATIVE ORGANISMS | GRAM POSITIVE ORGANISMS | GROUP D STREPTOCOCCUS | INCLUDING SECONDARY INVADERS | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | POST PARTURIENT BACTERIAL INFE | PRIMARY BACTERIAL INFECTION | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | SEBORRHOEIC DERMATITIS | STAPHYLOCOCCUS SPP. | SULFADIAZINE SENSITIVE BACTERI | TONSILLITIS | TRIMETHOPRIM SENSITIVE BACTERI | TYLOSIN SENSITIVE BACTERIA

Sommarju tal-prodott:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [BACTERIAL INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, INFECTIOUS SINUSITIS, STAPHYLOCOCCUS INTERMEDIUS, WOUND INFECTIONS]; DOG: [BACTERIAL INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, INFECTIOUS SINUSITIS, STAPHYLOCOCCUS INTERMEDIUS, WOUND INFECTIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [BACTERIAL INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, INFECTIOUS SINUSITIS, STAPHYLOCOCCUS INTERMEDIUS, WOUND INFECTIONS]; DOG: [BACTERIAL INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, INFECTIOUS SINUSITIS, STAPHYLOCOCCUS INTERMEDIUS, WOUND INFECTIONS]; Antibacterial for use in dogs and cats: Urinary tract infections; respiratory infections; deep pyodermas; wounds, abscesses & discharging sinuses. Etc… Exotic animals (small mammals, reptiles and avian species): Bacterial infections of alimentary & respirDO NOT USE in food producing species of animals. FOR USE in companion animals where culture and sensitivity testing indicates no suitable alternatives.

L-istatus ta 'awtorizzazzjoni:

Stopped

Data ta 'l-awtorizzazzjoni:

2023-07-01

Fuljett ta 'informazzjoni

PACK INSERT
Issue Date: 8-4-2010
Page: 1 of 12
_The information above this line is not included in the label _
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
BAYTRIL
® 25 FLAVOUR ANTIBACTERIAL ORAL SUSPENSION
DESCRIPTION:
Enrofloxacin is a synthetic drug from the class of the quinolone
carboxylic acid derivatives, also
known as fluoroquinolones. It has antibacterial activity against a
broad spectrum of gram negative and
gram positive bacteria, including Mycoplasma. (See Table 1). It is
rapidly absorbed from the
digestive tract, penetrating into all measured body tissues and fluids
(See Table 2).
Enrofloxacin has the chemical name
1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-
oxo-3-quinolinecarboxylic acid.
MICROBIOLOGY:
Enrofloxacin exerts bactericidal activity by interaction with the A
subunit of DNA gyrase in the target
bacteria. The DNA gyrase is a topoisomerase which controls bacterial
replication, i.e., it catalyses
supercoiling by rewinding and rejoining of chromosomal DNA strands.
The fluoroquinolones also
possess activity against bacteria in the stationary phase by an
alteration of the permeability of the outer
membrane phospholipid layer of the cell wall. These mechanisms of
action explain the rapid loss of
viability of susceptible bacteria. With enrofloxacin, inhibitory and
bactericidal concentrations are
closely correlated. They are identical or differ in many cases within
one or two dilution steps at
maximum.
Enrofloxacin
possesses
antimicrobial
activity
at
low
concentration
against
most
gram
negative
bacteria, many gram positive bacteria and against mycoplasmas.
Enrofloxacin is therefore active
against the micro-organisms that are primarily or secondarily involved
in many of the infectious
diseases which occur in small animals.
Info
PEST


Verified
PACK INSERT
Issue Date: 8-4-2010
Page: 2 of 12
_The information above this line is not included in the label _
TABLE 1
. Minimum Inhibitory Concentrations for enrofloxacin against pathogens
isolated f